Overview
Carsten Scholz practices practicing medicine in Zurich, Switzerland.
Mr. Scholz is highly rated in 1 condition, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Anemia, and Inflammatory Breast Cancer.
He is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Carsten C. Scholz
Is Carsten C. Scholz a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Carsten C. Scholz is classified as an Advanced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Carsten C. Scholz participate in research or clinical trials?
Yes. Carsten C. Scholz has published 36 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Carsten C. Scholz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral HypoxiaMr. Scholz isAdvanced. Learn about Cerebral Hypoxia.
- Experienced
- AnemiaMr. Scholz isExperienced. Learn about Anemia.
- Inflammatory Breast CancerMr. Scholz isExperienced. Learn about Inflammatory Breast Cancer.